Product Information
AUSTEDO XR 36 MG TABLET is a brand product labeled by Teva Neuroscience, Inc., priced at $418.5464 per EA under NDC 68546047456. Its NADAC has been published 92 times since Nov 20, 2024.
FDA first approved this application on Feb 17, 2023.
Strength
36 mg/1
Manufacturer
Teva Neuroscience, Inc.NDC
68546047456
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DEUTETRABENAZINEApproval Type
New Drug (NDA)
FDA Application
NDA216354FDA Approved
2/17/2023
On Market Since
5/29/2024
Price Statistics
The NADAC for AUSTEDO XR 36 MG TABLET has been published 92 times since Nov 20, 2024, and over the history we have for it it has risen 7.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $418.5464 per EA |
|---|---|
| All-time high | $421.0770 (Jul 15, 2026) |
| All-time low | $389.3786 (Dec 18, 2024) |
| 52-week high | $421.0770 |
| 52-week low | $394.3131 |
| Median price | $399.1131 |
| Average price | $404.0541 |
| Largest weekly change | +5.5% (Jan 7, 2026) |
| Weeks tracked | 92 |
| Tracking since | Nov 20, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the deutetrabenazine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AUSTEDO XR 36 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AUSTEDO XR 36 MG TABLET, manufactured by Teva Neuroscience, Inc., is $418.5464 per EA (NDC 68546047456), effective Aug 19, 2026.
How has the price of AUSTEDO XR 36 MG TABLET changed over time?
Over the history we have for it, the NADAC for AUSTEDO XR 36 MG TABLET has risen 7.4%. It has been tracked across 92 weekly CMS publications since Nov 20, 2024.
What are the highest and lowest recorded NADAC prices for AUSTEDO XR 36 MG TABLET?
Since Nov 20, 2024, the NADAC for AUSTEDO XR 36 MG TABLET has ranged from a low of $389.3786 (Dec 18, 2024) to a high of $421.0770 (Jul 15, 2026), with a median of $399.1131 per EA.
Are there cheaper alternatives to AUSTEDO XR 36 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of AUSTEDO XR 36 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AUSTEDO XR 36 MG TABLET?
AUSTEDO XR 36 MG TABLET (NDC 68546047456) is labeled by Teva Neuroscience, Inc., and CMS classifies it as a brand product.